|
WARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.180000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.820000E-02 |
| Normal-vs-Stage2 |
9.591000E-01 |
| Normal-vs-Stage3 |
2.428600E-01 |
| Normal-vs-Stage4 |
7.325800E-01 |
| Stage1-vs-Stage2 |
2.921200E-01 |
| Stage1-vs-Stage3 |
8.809200E-01 |
| Stage1-vs-Stage4 |
6.561200E-01 |
| Stage2-vs-Stage3 |
3.918000E-01 |
| Stage2-vs-Stage4 |
7.750000E-01 |
| Stage3-vs-Stage4 |
6.655200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.383320E-03 |
| Normal-vs-AfricanAmerican |
6.463400E-01 |
| Normal-vs-Asian |
8.590400E-01 |
| Caucasian-vs-AfricanAmerican |
9.073600E-02 |
| Caucasian-vs-Asian |
5.861000E-01 |
| AfricanAmerican-vs-Asian |
9.642600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00629999999436E-05 |
| Normal-vs-Female |
7.271800E-01 |
| Male-vs-Female |
4.498900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.167900E-02 |
| Normal-vs-Extreme_Weight |
7.595000E-04 |
| Normal-vs-Obese |
4.787600E-02 |
| Normal-vs-Extreme_Obese |
7.471200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.197200E-01 |
| Normal_Weight-vs-Obese |
7.656600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.938800E-01 |
| Extreme_Weight-vs-Obese |
2.898600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.049900E-02 |
| Obese-vs-Extreme_Obese |
3.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.826800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.978000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.239100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.650300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.222400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.813700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.344200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.263200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.620600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.757940E-03 |
| Normal-VS-Type2 PRCC |
1.754360E-01 |
| Normal-VS-KIRP CIMP |
6.864800E-01 |
| Normal-VS-Unclassified PRCC |
5.851000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.969800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.713800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.514000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.609400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.656800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.290000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.746000E-02 |
| Normal-vs-N1 |
6.172800E-01 |
| Normal-vs-N2 |
7.686200E-01 |
| N0-vs-N1 |
5.008600E-01 |
| N0-vs-N2 |
3.354000E-01 |
| N1-vs-N2 |
5.973200E-01 |
|
|
